Scientific Program

HALL A
08.00 - 09.15 OPENING
08.00 - 08.15 Opening Meltem Alkan Melikoğlu
Şebnem Ataman
08.15 - 08.35 TLAR Network and BIOSTAR SpA data
TLAR BIOSTAR RA data
Hatice Bodur
Şebnem Ataman
08.35 - 09.15 Messages from the pharmaceutical companies
  Amgen & Gensenta CEO Güldem Berkman
  MSD Turkey Region CEO Gözde Güllüoğlu
  Novartis Pharmaceuticals CEO Avinash Potnis
  Pfizer Turkey CEO Cem Açık
  Roche Turkey CEO Natasa Klicko
09.15 - 09.20 BREAK
09.20 - 10.35 LAST ONE YEAR WITH COVID-19 IN RHEUMATOLOGY
  Chairs: Hatice Bodur, Hilal Ecesoy, Kenan Tan
09.20 - 09.40 Post covid-19 systemic syndrome Hilal Ecesoy
09.40 - 10.00 Post covid-19 muscle neuromuscular syndromes Fatma Gül Yurdakul
10.00 - 10.20 Management of rheumatic diseases during covid-19 pandemic Abdulvahap Kahveci
10.20 - 10.35 Discussion
10.35 - 10.40 BREAK
10.40 - 11.25 EFFECTIVE AND LONG TERM PROTECTION IN OSTEOPOROSIS WITH PROLIA®
SATELLITE SYMPOSIUM (With Unconditional Support of Amgen)
  Chair: Tuncay Duruöz
    Özgür Akgül
Ece Akyüz
11.25 - 11.30 BREAK
11.30 - 12.30 DISCUSSION SESSION
  Chair: Zafer Günendi
  RA Are JAK inhibitors in RA before or after biologics? Lale Altan
Murat Birtane
12.30 - 13.00 LUNCH BREAK
13.00 - 14.15 SPONDYLOARTHROPATHIES
  Chairs: Sami Hizmetli, Akın Erdal, Şehim Kutlay
13.00 - 13.20 IL-17, 23 and other sytokine targets; lessons from clinical trials for SpA Joerg Ermann
13.20 - 13.40 SpA diagnosis update Sami Hizmetli
13.40 - 14.00 What's new in SpA therapy? Akın Erdal
14.00 - 14.15 Discussion
14.15 - 14.20 BREAK
14.20 - 15.05 SECUKINUMAB DIFFERENCE IN ANKYLOSING SPONDYLITIS: AXIAL AND PERIPHERAL UPTAKE
SATELLITE SYMPOSIUM (With Unconditional Support of Novartis)
  Chair: İlker Yağcı
  Axial uptake in ankylosing spondylitis and secukinumab Hilal Ecesoy
  Peripheral uptake in ankylosing spondylitis and secukinumab Erhan Çapkın
15.05 - 15.10 BREAK
15.10 - 16.25 INFLAMMATORY PATHWAYS AND DISEASE BURDEN IN RA
  Chairs: Şebnem Ataman, Vedat Hamuryudan, Hatice Bodur
15.10 - 15.30 Antibodies in RA; new roles in the pathogenesis and treatment Miriam A Shelef
15.30 - 15.35 Q&A
15.35 - 15.55 Disease burden in rheumatoid arthritis H. Fatih Çay
15.55 - 16.00 Q&A
16.00 - 16.20 New prospects in the treatment of rheumatoid arthritis Ronald F. van Vollenhoven
16.20 - 16.25 Q&A
16.25 - 16.30 BREAK
16.30 - 17.15 BARICITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: GOAL IS BEYOND THE STANDARD
SATELLITE SYMPOSIUM (With Unconditional Support of Lilly)
  Chair: Hatice Bodur
  Romatoid artrit tedavisinde barisitinib: hedef standardın ötesi Şebnem Ataman
Ayşen Akıncı
17.15 - 17.20 BREAK
17.20 - 18.20 PSORIATIC ARTHRITIS
  Chairs: Kemal Nas, Ömer Kuru, Hakan Genç
17.20 - 17.35 Psoriatic arthritis; hints for diagnosis İsmihan Sunar
17.35 - 17.55 PsA as an entheseal disease- from pathophysiology to treatment Georg Schett
17.55 - 18.10 Current treatments for psoriatic arthritis Yeliz Arıcan Zahiroğlu
18.10 - 18.20 Discussion
18.20 - 18.25 BREAK
18.25 - 20.25 TLAR RAD IMAGING SCHOOL
  Chairs: Özgür Akgül, Erhan Çapkın
18.25 - 18.45 Introduction and basic structures for musculoskeletal ultrasound Zafer Günendi
18.45 - 19.05 Ultrasound in rheumatoid arthritis Erhan Çapkın
19.05 - 19.25 Ultrasound in spondyloarthropathies İlker Yağcı
19.25 - 19.45 Ultrasound in crystal arthritis Özgür Akgül
19.45 - 20.15 Round-table discussion İlhan Sezer
08.00 - 09.15 SLE
  Chairs: Meltem Alkan Melikoğlu, Fatoş Önen, Mustafa Çalış
08.00 - 08.20 What's new in SLE diagnosis? Nihan Balta
08.20 - 08.40 What's new in SLE treatment? Meltem Alkan Melikoğlu
08.40 - 09.00 Evolving concepts in SLE damage assessments Ian N. Bruce
09.00 - 09.15 Discussion
09.15 - 09.20 BREAK
09.20 - 10.35 GOLDEN MEMORIES
  Chair: Meltem Alkan Melikoğlu
  Tansu Arasıl, Nurten Eskiyurt
Vesile Sepici, Ender Berker, Mehmet Beyazova
10.35 - 10.40 BREAK
10.40 - 11.25 SATELLITE SYMPOSIUM (With Unconditional Support of ABBVIE)
  Chair: Şebnem Ataman
  Ankilozan Spondilit Tedavisinde Hasta Perspektifi İlhan Sezer
11.25 - 11.30 BREAK
11.30 - 12.30 DISCUSSION SESSION
  Chair: Hilal Ecesoy
  Should T2T be a goal in SpA? Shall we discontinue medication in remission? Erhan Çapkın
Gamze Kılıç
12.30 - 13.00 LUNCH BREAK
13.00 - 14.15 COLLAGEN TISSUE DISEASES
  Chairs: Remzi Çevik, Gülcan Gürer
13.00 - 13.20 Sjogren syndrome update Mehmet Çağlayan
13.20 - 13.40 Treatment of interstitial lung disease in systemic sclerosis Richard Silver
13.40 - 14.00 Myositis update Nedim Kaban
14.00 - 14.15 Discussion
14.15 - 14.20 BREAK
14.20 - 15.05 ONE LIFE, ONE TOUCH: OUR SIMPONI EXPERIENCE FOR MORE THAN 8 YEARS IN SPONDYLOARTHROPATHY TREATMENT
SATELLITE SYMPOSIUM (With Unconditional Support of MSD)
  Chair: Meltem Alkan Melikoğlu
14.20 - 14.25 Opening Meltem Alkan Melikoğlu
14.25 - 14.40 Clinical experience with simponi for spondyloarthropathy İlhan Sezer
14.40 - 14.55 From real life data to our clinical experience with simponi in spondyloarthropathy Derya Buğdaycı
14.55 - 15.05 Q&A
15.05 - 15.10 BREAK
15.10 - 16.10 PROBLEMS ASSOCIATED WITH COLLAGEN TISSUE DISEASES
  Chairs: İlhan Sezer, Hasan Toktaş
15.10 - 15.35 Raynoud and digital ulcer Ali Nail Demir
15.35 - 16.00 Pulmonary hypertension İsmail Uçar
16.00 - 16.10 Discussion
16.10 - 16.15 BREAK
16.15 - 17.15 RA TREATMENT
  Chairs: Tuncay Duruöz, H. Fatih Çay
16.15 - 16.35 How I treat difficult RA? Joan Bathon
16.35 - 17.00 Rheumatoid arthritis treatment update Tuncay Duruöz
17.00 - 17.15 Discussion
17.15 - 17.20 BREAK
17.20 - 18.20 PAST, PRESENT AND FUTURE OF RHEUMATOLOGY; ARTIFICIAL INTELLIGENCE AND TELE-MEDICINE PRATICES IN RHEUMATOLOGY
  Chairs: Füsun Ardıç, Özgür Akgül, Murat Birtane
17.20 - 17.35 Past and present of rheumatology Coşkun Zateri
17.35 - 17.55 Artificial intelligence in medicine Okan Çalıyurt
17.55 - 18.10 Tele-medicine John Cush
18.10 - 18.20 Discussion
18.20 - 18.25 BREAK
18.25 - 20.25 IMMUNOLOGY SCHOOL
  Chair: Feride Göğüş
18.25 - 18.50 Innate immune response Füsun Özmen
18.55 - 19.20 Adaptive immune response Resul Karakuş
19.25 - 19.50 MHC + antigen presentation Ali Şengül
19.55 - 20.25 Immune tolerance and autoimmunity Göksal Keskin
08.00 - 09.15 OSTEOARTHRITIS
  Chairs: Tiraje Tuncer, Simin Hepgüler, Vural Kavuncu
08.00 - 08.20 Is osteoarthritis an inflammatory disease? Hilal Yeşil
08.20 - 08.40 Can osteoarthritis be prevented? Hatice Uğurlu
08.40 - 09.00 Treatment of osteoarthritis; to whom, how and when? Simin Hepgüler
09.00 - 09.15 Discussion
09.15 - 09.20 BREAK
09.20 - 10.35 METABOLIC BONE DISEASES
  Chairs: Lale Cerrahoğlu, Yeşim Kirazlı, Çiğdem Bircan
09.20 - 09.35 Calcium and Vitamin D: How much, when and how? Funda Çalış
09.35 - 09.55 Why does osteoporosis develop in rheumatic diseases and what are the treatment principles? Tunay Sarpel
09.55 - 10.10 Current pharmacological treatment in osteoporosis Dilşad Sindel
10.10 - 10.25 Which exercises are suggested for osteoporosis? Which orthesis to be used when? Ayşe Küçükdeveci
10.25 - 10.35 Discussion
10.35 - 10.40 BREAK
10.40 - 11.25 SATELLITE SYMPOSIUM (With Unconditional Support of ABBVIE)
  Chair: Şebnem Ataman
  Ankilozan Spondilit Tedavisinde Hasta Perspektifi İlhan Sezer
11.25 - 11.30 BREAK
11.30 - 12.30 REGIONAL PAIN I
  Chairs: Dilek Keskin, Filiz Sivas
11.30 - 11.55 Upper extremity pain Kenan Akgün
11.55 - 12.20 Lower extremity pain İlknur Aktaş
12.20 - 12.30 Discussion
12.30 - 13.00 LUNCH BREAK
13.00 - 14.15 REGIONAL PAIN II
  Chairs: Evren Yaşar, Kadriye Öneş, Figen Tuncay
13.00 - 13.20 Cervical pain Aylin Rezvani
13.20 - 13.40 Thoracic pain Figen Ayhan
13.40 - 14.00 Lumbar pain Ajda Bal
14.00 - 14.15 Discussion
14.15 - 14.20 BREAK
14.20 - 15.05 ONE LIFE, ONE TOUCH: OUR SIMPONI EXPERIENCE FOR MORE THAN 8 YEARS IN SPONDYLOARTHROPATHY TREATMENT
SATELLITE SYMPOSIUM (With Unconditional Support of MSD)
  Chair: Meltem Alkan Melikoğlu
14.20 - 14.25 Opening Meltem Alkan Melikoğlu
14.25 - 14.40 Clinical experience with simponi for spondyloarthropathy İlhan Sezer
14.40 - 14.55 From real life data to our clinical experience with simponi in spondyloarthropathy Derya Buğdaycı
14.55 - 15.05 Q&A
15.05 - 15.10 BREAK
15.10 - 16.10 FIBROMYALGIA AND SOFT TISSUE RHEUMATISM
  Chairs: Ali Gür, Mahir Uğur, Onur Armağan
15.10 - 15.30 Does fibromyalgia confusion still continue? Yeşim Kurtaiş Aytür
15.30 - 15.45 Myofascial pain Ayhan Kul
15.45 - 16.00 Soft tissue rheumatism Fatih Baygutalp
16.00 - 16.10 Discussion
16.10 - 16.15 BREAK
16.15 - 17.15 NON-PHARMACOLOGICAL APPROACHES IN INFLAMMATORY RHEUMATIC DISEASES
  Chairs: Ayşegül Ketenci, Demirhan Dıraçoğlu, Jale İrdesel
16.15 - 16.30 Complementary medicine approach to inflammatory diseases Cihan Aksoy
16.30 - 16.45 Exercise in inflammatory diseases Pelin Yıldırım
16.45 - 17.00 Physical therapy agents in inflammatory diseases Nalan Çapan
17.00 - 17.15 Discussion
17.15 - 17.20 BREAK
17.20 - 18.20 PAIN IN INFLAMMATORY RHEUMATIC DISEASES
  Chairs: Zuhal Altay, Gül Devrimsel, Banu Kuran
17.20 - 17.35 Pain mechanisms Ayşen Akıncı
17.35 - 17.50 Central pain management in inflammatory rheumatic diseases Savaş Şencan
17.50 - 18.05 Interventional procedures in pain Hakan Gündüz
18.05 - 18.20 Discussion
18.20 - 18.25 BREAK
18.25 - 20.25 ARTICLE LITERACY COURSE
  Chair: İlker Yağcı
18.25 - 18.55 Before writing a scientific article: Article reading, research planning and journal selection İlker Yağcı
18.55 - 19.25 Things to consider when writing? What do guides suggest? Esra Giray
19.25 - 19.55 What happened to my article? Operational process of journals Özge Keniş Coşkun
19.55 - 20.25 Discussion: frequently made mistakes on examples; İlker Yağcı, Esra Giray, Özge Keniş Coşkun
08.00 - 08.50   ORAL PRESENTATIONS
    Chairs: Ayhan Kamanlı, Kıvanç Cengiz
08.00 - 08.05 S-001 Impact of Subclinical Synovitis on Knee Joint Proprioception In Rheumatoid Arthritis Patients Musa Polat
08.05 - 08.10 S-002 Significant Side Effect of Rituximab Treatment: Hypogammaglobulinemia Rezan Koçak Ulucaköy
08.10 - 08.15 S-003 Association of Foot Pain With Disease Activity, Quality of Life and Concern of Falls in Rheumatoid Arthritis Merve Akdeniz Leblebicier
08.15 - 08.20 S-005 Assessment of Neuropathic Pain Components in Patients Diagnosed with Rheumatoid Arthritis Emel Atar
08.20 - 08.25 S-006 Assessment of 'Moral Welfare Level' in Rheumatoid Arthritis and Ankylosing Spondylitis Patients Emine Burcu Çomruk
08.25 - 08.30 S-007 Are Platelet and Leucocyte Parameters Associated with Disease Activation in Rheumatoid Arthritis Patients? Melda Ulaş Güncan
08.30 - 08.35 S-008 Comparison of 24 hours of ambulatory blood pressure and arteriosclerosis index measurement results of PAH patients associated with connective tissue and other group 1 PAH patients Vedat Hekimsoy
08.35 - 08.50   Q&A
BREAK
09.20 - 10.10   ORAL PRESENTATIONS
    Chairs: Akın Erdal, Ajda Bal
09.20 - 09.25 S-009 Impact of Benign Joint Hypermobility Syndrome on Carpal Tunnel Syndrome Clinic in Women Serap Satış
09.25 - 09.30 S-010 Relationship between falls and fatigue, fear of falls, emotional status and quality of life in pregnant women İlknur Can
09.30 - 09.35 S-011 Reflection of sensory findings on central nervous system in patients with neuropathic pain: A functional MRI and quantitative sense test study Göksel Tanıgör
09.35 - 09.40 S-012 Impact of Time Between Emergence of Symptoms and Electrophysiological Diagnosis in Carpal Tunnel Syndrome Patients on Quality of Life, Quality of Sleep and Psychological Status: Preliminary Results Damla Cankurtaran
09.40 - 09.45 S-014 Impact of Balneotherapy on Vital Signs Sevda Adar
09.45 - 09.50 S-015 Evaluation of the relationship between median and ulnar nerve electrophysiological findings and upper extremity functions in chronic stroke patients Selma Eroğlu
09.50 - 09.55 S-016 Pain Management of Patients Whose Social Life Has Been Restricted due to Covid 19 Pandemic Zeynep Kılıç
09.55 - 10.10   Q&A
BREAK
13.00 - 13.50   ORAL PRESENTATIONS
    Chairs: Ece Kaptanoğlu, Murat Karkucak
13.00 - 13.05 S-017 Assessment of the relationship between common carotid artery intima media thickness and disease activity in female fibromyalgia patients Dilek Eker Büyükşireci
13.05 - 13.10 S-018 Assessment of the Physical and Emotional Impact of COVID-19 Pandemic on Fibromyalgia Syndrome Patients: Polycentric, Cross-sectional, Controlled Study Fatih Bağcıer
13.10 - 13.15 S-019 Comparison of Local Anesthesic Administered on Trigger Points and Mesotherapy in Myofascial Pain Syndrome Nilüfer Aygün Bilecik
13.15 - 13.20 S-020 Rheumatic Diseases Accompanying Fibromyalgia Syndrome: Single Center Experience Betül Sargın
13.20 - 13.25 S-023 Assessment of the Relationship Between Postmenopausal Osteoporosis and Metabolic Syndrome and Physical Activity Level Zeynep Tuba Bahtiyarca
13.25 - 13.30 S-021 Are Carpal Tunnel Syndrome and Serum C-Reactive Protein/Albumin Ratio Related?
Tuba Erdem Sultanoğlu
13.30 - 13.35 S-022 Assessment of the impact dexamethasone iontophoresis, galvanic current and standardised physiotherapy have on pain and disability in knee osteoarthritis patients with Baker cyst: prospective, randomised controlled single blind study Dilek Eker Büyükşireci
13.35 - 13.50   Q&A
BREAK
15.10 - 16.00   ORAL PRESENTATIONS
    Chairs: Cahit Kaçar, Özgür Akgül
15.10 - 15.15 S-024 Comparison of the Ultrasound Findings in Gout Arthritis and Dual Energy CT Findings Murat Toprak
15.15 - 15.20 S-025 Gender based clinical features and differences in the severity of the disease in Familial Mediterranean Fever: Preliminary results Aygun Ozer
15.20 - 15.25 S-026 Evaluation of the Geographical Differences Among the Familial Mediterranean Fever Patients in Turkey: Preliminary Study Results Halise Hande Gezer
15.25 - 15.30 S-027 Evaluation of Autoantibody Levels of Sarcoidosis Patients Nesrin Şen
15.30 - 15.35 S-028 Assessment of Articular Cartilage in Acromegalic Patients with Semi-Quantitative Ultrasound Scoring System: A Pilot Study Sinem Kübra Konca
15.35 - 15.40 S-029 Prognostic Nutritional Index and Inflammatory Markers in Familial Mediterranean Fever (FMF) Patients Hasan Sözel
15.40 - 15.45 S-004 Impact of Covid-19 Pandemic on Our Patients That Are on Anti-Tnf Drug at our Clinic Özlem Küçülmez
15.45 - 16.00   Q&A
BREAK
16.15 - 17.00   ORAL PRESENTATIONS
    Chairs: Hüseyin Demir, Hilal Ecesoy
16.15 - 16.20 S-030 Evaluation of Sarcopenia Frequency and its Relation With Clinical and Laboratory Findings in Ankylosing Spondylitis Patients Melike Ergün
16.20 - 16.25 S-031 Presence of enthesitis and its relation with ASAS Health Index in Axial Spondylarthritis patients: pilot study Abdulvahap Kahveci
16.25 - 16.30 S-032 Assessment of Cardiometabolic Risk Factors in Ankylosing Spondylitis Patients Kemal Nas
16.30 - 16.35 S-033 Fetuin-A, Interleukin-18, Endothelin-1 and sICAM-1 levels and their relation with Anti-Tnf-α therapies in Ankylosing Spondylitis patients Neytullah Turan
16.35 - 16.40 S-034 Relationship of Sacroiliac Periarticular Ligaments and Lumbar Spinal Stabilisers in Axial Spondyloarthropathy Patients and the Possible Impact of Disease Activity on These Parameters - Pilot Study Seçilay Güneş
16.40 - 16.45 S-035 Relationship of Myofascial Pain and Morphological Features of Thoracolumbar Fascia and Disease Associated Parameters in Axial Spondyloarthropathy Patients Yuzlem Gyuner Sidzhimli
16.45 - 17.00   Q&A
BREAK
17.20 - 18.10   ORAL PRESENTATIONS
    Chairs: Erkan Kozanoğlu, Zafer Günendi
17.20 - 17.25 S-036 Analysis of the Relationship Between Coronavirus Phobia and Disease Parameters in Spondylarthritis Patients that are on bDMARD Nurbanu Hindioğlu
17.25 - 17.30 S-037 Impact of social status on clinical parameters in female PsA patients İbrahim Tekeoğlu
17.30 - 17.35 S-038 Validity and psychometric features of Psoriatic Arthritis Quality of Life survey (PsAQoL) in Turkish society Sevtap Acer Kasman
17.35 - 17.40 S-039 Family history of rheumatic diseases in Psoriatic Arthritis patients: Polycentric, cross-sectional study Kemal Nas
17.40 - 17.45 S-040 Comparison of Sacroiliac MRI Scores and Disease Activity in Axial Psoriatic Arthritis Halise Hande Gezer
17.45 - 17.50 S-041 Search on Hepatitis Serology in Patients that Use Biological Agent: Polycentric Observational TLAR - Network Study Erhan Çapkin
17.50 - 17.55 S-013 Continuity of Treatment and Anxiety Levels in Chronic Rheumatic Diseases Within the Pandemic Process Nuran Eyvaz
17.55 - 18.10   Q&A
BREAK
18.25 - 19.10   ORAL PRESENTATIONS
    Oturum Başkanları: Lale Altan, Fatih Çay
18.25 - 18.30 S-042 Lumbar Region Diseases that Accompany Symptomatic Lumbar Lordosis Flattening Fatih Baygutalp
18.30 - 18.35 S-043    
18.35 - 18.40 S-044 Comparison of Clinical Efficacy of Kinesiological Taping and Extracorporeal Shockwave Therapy in Lateral Epicondylitis Patients Hülya Deveci
18.40 - 18.45 S-045 Assessment of the relationship between disease severity and neuropathic pain, sleep, fatigue, quality of life and mood in carpal tunnel syndrome Cagri Unal Ulutatar
18.45 - 18.50 S-046 Connection of Burn-out Syndrome with Lower Back Pain, Neck Pain and Psychological Status Among Hospital Staff During Covid Time İlknur Aykurt Karlıbel
18.50 - 18.55 S-047 Search on Efficacy of Transdermal Diffusional Patch Application in Cervical Disk Herniation Patients: placebo-controlled study Hüseyin Çolak
18.55 - 19.10   Q&A
BREAK
19.10 - 19.55   ORAL PRESENTATIONS
    Chairs: İlhan Sezer, Erhan Çapkın
19.10 - 19.15 S-048 Assessment of Lumbar Magnetic Resonance Imaging findings in pediatric patients that are admitted with lower back pain Aynur Metin Terzibaşıoğlu
19.15 - 19.20 S-049 Impact of Platelet Rich Plasma and Dextrose Prolotherapy Injections on Cardiac Injury Specific Enzymes Özlem Karasimav
19.20 - 19.25 S-050 Promising Treatment Approach in Coccydynia Patients: Dextrose Prolotherapy Mert Zure
19.25 - 19.30 S-051 Comparison of extracorporeal shockwave therapy (ESWT) with conventional physiotherapy agents' efficacy on pain, disability, functional status and depression in chronic lower back pain patients: Randomised controlled study Fatmanur Aybala Koçak
19.30 - 19.35 S-052 Can ‘Neutrophil To Lymphocyte Ratio (NLR) And Platelet To Lymphocyte Ratio(PLR) ‘ be useful biomarkers for hand involvement in diabetic patients? Sinan Bağçacı
19.35 - 19.40 S-053 Relationship of radiologically assessed facet joint osteoarthritis and lumbar discopathy stages with clinical findings Büşra Yılmaz
19.40 - 19.55   Q&A
08.00 - 09.15 VASCULITIS
  Chairs: Cahit Kaçar, Ece Kaptanoğlu, Yunus Durmaz
08.00 - 08.20 Treatment of ANCA associated vasculitis in 2021 Sharon A Chung
08.20 - 08.40 Polymyalgia rheumatica and giant cell arteritis Ülkü Uçar
08.40 - 09.00 Symptoms that make one consider vasculitis Sevcan Uğur
09.00 - 09.15 Discussion
09.15 - 09.20 BREAK
09.20 - 10.35 BEHCET'S SYNDROME
  Chairs: Feride Göğüş, Selda Sarıkaya, Gülçin Kaymak Karataş
09.20 - 09.40 Pathogenesis in Behcet's Syndrome Feride Göğüş
09.40 - 10.00 Clinic in Behcet's Syndrome Zafer Günendi
10.00 - 10.20 Treatment in Behcet's Syndrome Serdar Can Güven
10.20 - 10.35 Discussion
10.35 - 10.40 BREAK
10.40 - 11.25 POWER THAT COMES FROM BIOTECHNOLOGY MAKES A DIFFERENCE: AMGEVİTA AND CLINICAL EXPERIENCE IN THE TREATMENT OF INFLAMMATORY RHEUMATIC DISEASES
SATELLITE SYMPOSIUM (With Unconditional Support of Amgen)
  Chair: Şebnem Ataman
    İlhan Sezer
Nilay Şahin
11.25 - 11.30 BREAK
11.30 - 12.30 DISCUSSION SESSION
  Chair: Akın Erdal
  Debatable subjects in diagnosis and treatment of osteoarthritis
Is an early osteoarthritis diagnosis possible?
Have treatment approaches changed?
Ayşegül Ketenci
Demirhan Dıraçoğlu
12.30 - 13.00 LUNCH BREAK
13.00 - 14.15 PEDIATRIC RHEUMATOLOGY
  Chairs: Özgür Kasapçopur, Meltem Alkan Melikoğlu
13.00 - 13.20 Childhood autoinflammatory diseases update Yelda Bilginer
13.20 - 13.40 Juvenile idiopathic arthritis update Balahan Bora Makay
13.40 - 14.00 Childhood connective tissue disorders update Sezgin Şahin
14.00 - 14.15 Discussion
14.15 - 14.20 BREAK
14.20 - 15.05 TOFACITINIB IN RHEUMATOID ARTHRITIS TREATMENT WITH CURRENT DATA
SATELLITE SYMPOSIUM (With Unconditional Support of Pfizer)
  Chair: Ömer Kuru
  Güncel verilerle romatoid artrit tedavisinde tofasitinib İlhan Sezer
Şebnem Ataman
15.05 - 15.10 BREAK
15.10 - 16.10 GERIATRIC RHEUMATOLOGY; APPROACH TO GERIATRIC PATIENT WITHIN CUMULATIVE PROBLEMS' SPIRAL
  Chairs: Yeşim Gökçe Kutsal, Nigar Dursun, Deniz Evcik
15.10 - 15.25 Polymyalgia rheumatica in geriatric patients; distinctive diagnosis and current treatment İlke Coşkun Benlidayı
15.25 - 15.40 Presentation of crystal arthropathies in geriatric patients and treatment principles Barış Nacır
15.40 - 15.55 Late onset RA in geriatric patients; clinical progress and treatment Ali Erhan Özdemirel
15.55 - 16.10 Discussion
16.10 - 16.15 BREAK
16.15 - 17.15 OTHER SYSTEMIC DISORDERS
  Chairs: Hüseyin Demir, Murat Karkucak, Nurdan Kotevoğlu
16.15 - 16.30 Sarcoidosis Gizem Cengiz
16.30 - 16.45 IgG4-related disease Kevser Gök
16.45 - 17.00 Adult still disease Kemal Erol
17.00 - 17.15 Discussion
17.15 - 17.20 BREAK
17.20 - 18.20 INFECTIOUS ARTHRITIS
  Chairs: Ayhan Bilgici, Nilay Şahin, Meltem Vural
17.20 - 17.35 Bacterial arthritis İlker İlhanlı
17.35 - 17.50 Chronic infective arthritis Nilay Şahin
17.50 - 18.05 Reactive arthritis Ayhan Bilgici
18.05 - 18.20 Discussion
18.20 - 18.30 BREAK
18.30 - 20.25 TLAR MICROSCOPIC IMAGING
18.30 - 19.25 CAPILLAROSCOPY COURSE
  Opening and moderation Şebnem Ataman
18.30 - 18.45 Definition of capillaroscopy, device features, indications and normal findings Alper Gümüştepe
18.45 - 19.05 Pathological capillaroscopic findings accompanied by cases Abdulvahap Kahveci
19.05 - 19.25 Capillaroscopy in the last year accompanied by articles Pınar Bora Karslı
19.25 - 20.25 SYNOVIAL FLUID ANALYSIS COURSE
  Opening and moderation Meltem Alkan Melikoğlu
19.30 - 19.45 Synovial fluid analysis indications - contraindications and its equipment Zeynep Tüzün
19.45 - 20.00 Macroscopic evaluations of synovial fluid Muhammet Recai Akdoğan
20.00 - 20.20 Microscopic evaluation of synovial fluid Ekin Doğancı
20.25 CLOSING, AWARDS
08.00 - 09.15 FMF AND OTHER AUTOINFLAMMATORY DISEASES
  Chairs: Ayhan Kamanlı, Savaş Gürsoy, Kıvanç Cengiz
08.00 - 08.20 FMF clinic and diagnostic approaches Cemal Gürbüz
08.20 - 08.40 Treatment and monitoring in FMF Ahmet Kıvanç Cengiz
08.40 - 09.00 Other autoinflammatory diseases Gökhan Çağlayan
09.00 - 09.15 Discussion
09.15 - 09.20 BREAK
09.20 - 10.35 APPROACH OF VARIOUS DISCIPLINES TO INFLAMMATORY RHEUMATIC DISEASES
  Chairs: Özgür Akgül, Meltem Alkan Melikoğlu, Ejder Berk
09.20 - 09.40 Inflammatory rheumatic diseases and eye Olcay Tatar
09.40 - 10.00 Inflammatory rheumatic diseases and lungs Pınar Çelik
10.00 - 10.20 Inflammatory rheumatic diseases and skin Mehmet Melikoğlu
10.20 - 10.35 Discussion
10.35 - 10.40 BREAK
10.40 - 11.25 POWER THAT COMES FROM BIOTECHNOLOGY MAKES A DIFFERENCE: AMGEVİTA AND CLINICAL EXPERIENCE IN THE TREATMENT OF INFLAMMATORY RHEUMATIC DISEASES
SATELLITE SYMPOSIUM (With Unconditional Support of Amgen)
  Chair: Şebnem Ataman
    İlhan Sezer
Nilay Şahin
11.25 - 11.30 BREAK
11.30 - 12.30 REASONABLE IMAGING FOR INFLAMMATORY RHEUMATIC DISEASES
  Chairs: Hayal Güler, Zafer Günendi
11.30 - 11.55 Radiology; radiological imaging in vasculitis Erkan Kılıç
11.55 - 12.20 Nuclear medicine; PET in rheumatic diseases Ümit Özgür Akdemir
12.20 - 12.30 Discussion
12.30 - 13.00 LUNCH BREAK
13.00 - 14.15 FROM SYMPTOM TO DIAGNOSIS
  Chairs: Günşah Şahin, Nurettin Taştekin, H. Fatih Çay
13.00 - 13.20 Patient that comes with uveitis Nurdan Oruçoğlu
13.20 - 13.40 Patient that comes with interstitial lung disease Pınar Bora Karslı
13.40 - 14.00 Patient that comes with vasculitic lesion report for cerebral MRI Hasan Ulusoy
14.00 - 14.15 Discussion
14.15 - 14.20 BREAK
14.20 - 15.05 TOFACITINIB IN RHEUMATOID ARTHRITIS TREATMENT WITH CURRENT DATA
SATELLITE SYMPOSIUM (With Unconditional Support of Pfizer)
  Chair: Ömer Kuru
  Güncel verilerle romatoid artrit tedavisinde tofasitinib İlhan Sezer
Şebnem Ataman
15.05 - 15.10 BREAK
15.10 - 16.10 SPECIAL CONDITIONS IN INFLAMMATORY RHEUMATIC DISEASES
  Chairs: Levent Ediz, Belgin Erhan, Taciser Kaya
15.10 - 15.25 Pregnancy in inflammatory rheumatic diseases Nurhan Güven
15.25 - 15.40 Immunisation in inflammatory rheumatic diseases Zühre Sarı Sürmeli
15.40 - 15.55 Surgical and other procedures in inflammatory rheumatic diseases Nesrin Şen
15.55 - 16.10 Discussion
16.10 - 16.15 BREAK
16.15 - 17.15 CRYSTAL ARTHROPATHIES
  Chairs: Erkan Kozanoğlu, Feray Cinevre Soyupek, Funda Levendoğlu
16.15 - 16.30 Gout Ömer Faruk Şendur
16.30 - 16.45 Pseudogout and others Hülya Uzkeser
16.45 - 17.00 Rational drug use Ekin Doğancı
17.00 - 17.15 Discussion
17.15 - 17.20 BREAK
17.20 - 18.20 PANEL ON THINGS WE WONDER ABOUT RHEUMATOLOGY
  Chairs: İbrahim Tekeoğlu, Ümit Dündar
17.20 - 17.35 Inflammatory rheumatic diseases and diet Gülnur Taşçı Bozbaş
17.35 - 17.50 Inflammatory rheumatic diseases and microbiota Öznur Kutluk
17.50 - 18.05 Inflammatory rheumatic diseases and gene therapies Sertaç Ketenci
18.05 - 18.20 Discussion
18.20 - 18.25 BREAK
18.30 - 20.25 MUSCULOSKELETAL SYSTEM PHSICAL EXMINATION COURSE
  Chair: H. Fatih Çay
18.30 - 19.00 Upper extremity examination Öznur Kutluk
19.00 - 19.30 Lower extremity examination Ülkü Uçar
19.30 - 20.00 Spinal examination H. Fatih Çay
20.00 - 20.25 Q&A
20.25 CLOSING, AWARDS

Important Dates

  • Deadline for Early Registration: 1 April 2021

  • Deadline for Abstract Submission: 16 April 2021

  • E-Congress System Opening Date: 28 May 2021

  • E-Congress System Closing Date: 30 May 2021